151213-42-2Relevant articles and documents
Moxifloxacin process for the preparation of intermediates (by machine translation)
-
, (2016/11/07)
The invention discloses a kind of Moxifloxacin process for the preparation of intermediates, MXC-1 with tetrahydrofurfuroxy pyrrolizinone condensation of the first, longer and acrylamide reaction produce MXC-2, MXC -2 passes through the reduction reaction produce MXC-3, MXC -3 hydrogenation to obtain MXC-4, to obtain a target product last MXC divided; the method step brief, the operation is simple, and is suitable for industrial mass production. (by machine translation)
Racemisation of (1R, 6S)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane using halogenated solvent in basic medium
Bhavsar, Jigar,Bhashkar, Bhuwan,Kumar, Anil
, p. 241 - 246 (2013/06/27)
A simple, highly rapid, efficient and eco friendly process for Racemisation of (1R, 6S)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0] nonane in various halogenated solvents has been carried out as a base catalysed reaction to afford racemic mixture in excellent yields (80-95%) at temperature of or below 40°C. The base catalysed racemisation in halogenated solvent has an advantage of simple workup procedure, and use of less volume of halogenated solvent irrespective of type of solvent used in the reaction system.
PHENYLAMINOPYRIMIDINES AND THEIR USE AS RHO-KINASE INHIBITORS
-
Page column 58, (2010/02/06)
The invention relates to the phenylaminopyrimidines of formula (I), wherein A, D, R1, R2, R3 and R4 are defined as in the description. The invention also relates to methods for producing said phenylaminopyrimidines and to their use for producing drugs for the treatment and/or the prophylaxis of diseases, especially cardiovascular diseases.